Stable Overexpression of Specific Segments of the P2P-R Protein in Human MCF-7 Cells Promotes Camptothecin-Induced Apoptosis

Journal of Cellular Physiology

Volumn 197, Issue 3, 2003, Pages 445-452

  Gao, S ^a   Scott, Robert E ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CASPASE 3; CELL PROTEIN; PROTEIN P2P R; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL POPULATION; CELL STRAIN MCF 7; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BINDING SITES; BREAST NEOPLASMS; CAMPTOTHECIN; CARRIER PROTEINS; CELL CYCLE; ENZYME INHIBITORS; HUMANS; MICE; NIH 3T3 CELLS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0344825900     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10381     Document Type: Article

References (23)

1. Doman RK, Perez M, Donato NJ. 1999. JNK and p53 stress signaling cascades are altered in MCF-7 cells resistant to tumor necrosis factor-mediated apoptosis. J Interferon Cytokine Res 19:261-269.
2. Fest T, Mougey V, Dalstein V, Hagerty M, Milette D, Silva S, Mai S. 2002. c-MYC overexpression in Ba/F3 cells simultaneously elicits genomic instability and apoptosis. Oncogene 21:2981-2990.
3. Fusaro G, Wang S, Chellappan S. 2002. Differential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptesis. Oncogene 21:4539-4548.
4. Gao S, Scott RE. 2002. P2P-R protein overexpression restricts mitotic progression at prometaphase and promotes mitotic apoptosis. J Cell Physiol 193:199-207.
5. Gao S, Witte MM, Scott RE. 2002. P2P-R protein localizes to the nucleolus of interphase cells and the periphery of chromosomes in mitotic cells which show maximum P2P-R immunoreactivity. J Cell Physiol 191:145-154.
6. Honig LS, Rosenberg RN. 2000. Apoptosis and neurological disease. Am J Med 108:317-330.
7. Janicke RU, Sprengart ML, Wati MR, Porter AG. 1998. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273:9357-9360.
8. Janicke RU, Engels IH, Dunkern T, Kaina B, Schulze-Osthoff K, Porter AG. 2001. Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells. Oncogene 20:5043-5053.
9. Kurokawa H, Nishio K, Fukumoto H, Tomonari A, Suzuki T, Saijo N. 1999. Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells. Oncol Rep 6:33-37.
10. Lauricella M, Calvaruso G, Carabillo M, D'Anneo A, Giuliano M, Emanuele S, Vento R, Tesoriere G. 2001. pRb suppresses camptothecin-induced apoptosis in human osteosarcoma Saos-2 cells by inhibiting c-Jun N-terminal kinase. FEBS Lett 499:191-197.
11. Li T-K, Liu LF. 2001. Tumor cell death induced by topoisomerase-targeting drugs. Annu Rev Pharmacol Toxicol 41:53-77.
12. Liu W, Zhang R. 1998. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways. Int J Oncol 12:793-804.
13. Miyata H, Doki Y, Yamamoto H, Kishi K, Takemoto H, Fujiwara Y, Yasuda T, Yano M, Inoue M, Shiozaki H, Weinstein IB, Monden M. 2001. Overexpression of CDC25B overrides radiation-induced G2-M arrest and results in increased apoptosis in esophageal cancer cells. Cancer Res 61:3188-3193.
14. Pommier Y, Leteurtre F, Fesen MR, Fujimori A, Bertrand R, Solary E, Kohlhagen G, Kohn KW. 1994. Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest 12:530-542.
15. Rudel T, Bokoch GM. 1997. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276:1571-1574.
16. Simons A, Melamed-Bessudo C, Wolkowicz R, Sperling J, Sperling R, Eisenbach L, Rotter V. 1997. PACT: Cloning and characterization of a cellular p53 binding protein that interacts with Rb. Oncegene 14:145-155.
17. Slee EA, Adrain C, Martin SJ. 1999. Serial killers: Ordering caspase activation events in apoptosis. Cell Death Differ 6:1067-1074.
18. Strasser A, O'Connor L, Dixit VM. 2000. Apoptosis signaling. Annu Rev Biochem 69:217-245.
19. Suyama E, Kawasaki H, Taira K. 2002. Identification of a caspase 3-independent role of pro-apoptotic factor Bak in TNF-alpha-induced apoptosis. FEBS Lett 528:63-69.
20. Swiatecka J, Dzieciol J, Anchim T, Dabrowska M, Pietruczuk M, Wolczynski S. 2000. Influence of estrogen, antiestrogen and UV-light on the balance between proliferation and apoptosis in MCF-7 breast adenocarcinoma cells culture. Neoplasma 47:15-24.
21. Wang H, Shao N, Ding QM, Cui J, Reddy ES, Rao VN. 1997. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 15:143-157.
22. Witte MM, Scott RE. 1997. The proliferation potential protein-related (P2P-R) gene with domains encoding heterogeneous nuclear ribonucleoprotein association and Rb1 binding shows repressed expression during terminal differentiation. Proc Natl Acad Sci USA 94:1212-1217.
23. Xu Z, Kukekov NV, Greene LA. 2003. POSH acts as a scaffold for a multiprotein complex that mediates JNK activation in apoptosis. EMBO J 22:252-261.